Literature DB >> 16830133

The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.

Brian Jeynes1, John Provias.   

Abstract

Recent studies have observed beta-amyloid-positive capillaries in lesion-prone regions of Alzheimer's disease (AD) brains. It is possible that there is a pathogenic link between neurofibrillary tangles (NFTs) and/or senile plaques (SPs) and altered capillary structure/function. In this study, we examined and compared brain tissue from a frequently observed NFT abundant area, the superior temporal cortex (ST), and a comparatively much NFT sparser area, the calcarine cortex (COC), in ten AD and ten normal adult control brain samples. We recorded the densities of NFTs, and beta-amyloid(8-17,40,42) peptide forms in SPs, capillaries and large vessels [cerebral amyloid angiopathy (CAA)] in these areas. Our results demonstrated that there was a significant difference between the means of NFT and SP beta(8-17,40) lesions when comparing the ST and COC cortical regions in both AD and control brains. In AD brains, we observed a positive correlation between NFTs and SPs in both regions, and between NFTs and beta-amyloid-positive capillaries and CAA vessels, particularly in the calcarine cortex. In addition, significant correlations were observed between some SP beta-amyloid peptide forms and CAA beta(42), in particular, in both regions. These new observations support the view that there are regional (focal) differences in the presence of each AD lesion, and that there may be a pathogenic relationship between the development of AD lesions and beta-amyloid-positive vessels. The data are also consistent with the concept that a focally dysfunctional blood-brain barrier (BBB) that is unable to regulate the influx/efflux of neurotoxic amyloid peptides may participate in the pathogenesis of AD lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830133     DOI: 10.1007/s00401-006-0099-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  11 in total

Review 1.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

2.  Neuropathologic Findings in Elderly HIV-Positive Individuals.

Authors:  Shino D Magaki; Harry V Vinters; Christopher K Williams; Sergey Mareninov; Negar Khanlou; Jonathan Said; Natasha Nemanim; Jessica Gonzalez; Jose G Morales; Elyse J Singer; William H Yong
Journal:  J Neuropathol Exp Neurol       Date:  2022-06-20       Impact factor: 3.148

Review 3.  The potential importance of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of Alzheimer's disease.

Authors:  Antero Salminen; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2018-05-19       Impact factor: 9.261

4.  Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.

Authors:  Verónica Berta Dorfman; Laura Pasquini; Miguel Riudavets; Juan José López-Costa; Andrés Villegas; Juan Carlos Troncoso; Francisco Lopera; Eduardo Miguel Castaño; Laura Morelli
Journal:  Neurobiol Aging       Date:  2008-11-18       Impact factor: 4.673

5.  The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.

Authors:  Shino Magaki; Zhaoyi Tang; Spencer Tung; Christopher K Williams; Darrick Lo; William H Yong; Negar Khanlou; Harry V Vinters
Journal:  Neurobiol Aging       Date:  2018-06-11       Impact factor: 4.673

Review 6.  Biological Hallmarks of Cancer in Alzheimer's Disease.

Authors:  Kelly N H Nudelman; Brenna C McDonald; Debomoy K Lahiri; Andrew J Saykin
Journal:  Mol Neurobiol       Date:  2019-04-16       Impact factor: 5.590

7.  Immunohistochemical detection of receptor-associated protein in normal human brain and Alzheimer's disease.

Authors:  John Provias; Brian Jeynes
Journal:  Patholog Res Int       Date:  2010

Review 8.  Current Management and Therapeutic Strategies for Cerebral Amyloid Angiopathy.

Authors:  Yasuteru Inoue; Yukio Ando; Yohei Misumi; Mitsuharu Ueda
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

9.  Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Dietmar R Thal; Thomas Arzberger; Nenad Bogdanovic; Safa Al-Sarraj; Istvan Bodi; Susan Boluda; Orso Bugiani; Charles Duyckaerts; Ellen Gelpi; Stephen Gentleman; Giorgio Giaccone; Manuel Graeber; Tibor Hortobagyi; Romana Höftberger; Paul Ince; James W Ironside; Nikolaos Kavantzas; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; David Meyronet; Camelia Monoranu; Tatjana Nilsson; Piero Parchi; Efstratios Patsouris; Maria Pikkarainen; Tamas Revesz; Annemieke Rozemuller; Danielle Seilhean; Walter Schulz-Schaeffer; Nathalie Streichenberger; Stephen B Wharton; Hans Kretzschmar
Journal:  Acta Neuropathol       Date:  2009-02-01       Impact factor: 17.088

10.  The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer's disease.

Authors:  J Provias; B Jeynes
Journal:  Int J Alzheimers Dis       Date:  2014-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.